Egmidio Medina

1.2k total citations
10 papers, 173 citations indexed

About

Egmidio Medina is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Egmidio Medina has authored 10 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Egmidio Medina's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Melanoma and MAPK Pathways (5 papers). Egmidio Medina is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Melanoma and MAPK Pathways (5 papers). Egmidio Medina collaborates with scholars based in United States, United Kingdom and Switzerland. Egmidio Medina's co-authors include Antoni Ribas, Katie M. Campbell, Gabriel Abril-Rodríguez, Davis Y. Torrejon, Ameya S. Champhekar, Jeffrey S. Weber, James Larkin, Timothy R. Howes, Michael J. Travers and Gabriela Steiner and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Cell and Cancer Research.

In The Last Decade

Egmidio Medina

10 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egmidio Medina United States 7 106 80 64 24 22 10 173
Sanam Peyvandi Switzerland 5 106 1.0× 87 1.1× 62 1.0× 33 1.4× 19 0.9× 9 182
Marnix Geukes Foppen Netherlands 4 130 1.2× 82 1.0× 98 1.5× 20 0.8× 16 0.7× 8 192
Mélanie Buchi Switzerland 5 133 1.3× 92 1.1× 67 1.0× 22 0.9× 30 1.4× 6 224
Samantha B. Kemp United States 7 123 1.2× 102 1.3× 86 1.3× 58 2.4× 23 1.0× 11 233
Joanne Leung Canada 5 92 0.9× 103 1.3× 41 0.6× 11 0.5× 14 0.6× 6 157
Madisson Oliwa United States 2 94 0.9× 91 1.1× 61 1.0× 33 1.4× 24 1.1× 3 164
Anamarija Markota Germany 4 82 0.8× 111 1.4× 61 1.0× 18 0.8× 22 1.0× 4 170
Bryant Harbourne Canada 5 81 0.8× 77 1.0× 95 1.5× 20 0.8× 20 0.9× 6 190
Mark Buckup United States 3 86 0.8× 85 1.1× 57 0.9× 20 0.8× 25 1.1× 4 161
Devora Delman United States 6 72 0.7× 44 0.6× 91 1.4× 23 1.0× 16 0.7× 8 188

Countries citing papers authored by Egmidio Medina

Since Specialization
Citations

This map shows the geographic impact of Egmidio Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egmidio Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egmidio Medina more than expected).

Fields of papers citing papers by Egmidio Medina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egmidio Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egmidio Medina. The network helps show where Egmidio Medina may publish in the future.

Co-authorship network of co-authors of Egmidio Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Egmidio Medina. A scholar is included among the top collaborators of Egmidio Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egmidio Medina. Egmidio Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Daniel, Jingyi Xie, Jongchan Choi, et al.. (2024). Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer. Cell Reports. 43(3). 113872–113872. 4 indexed citations
2.
Champhekar, Ameya S., Justin D. Saco, June Lee, et al.. (2023). ERK mediates interferon gamma-induced melanoma cell death. Molecular Cancer. 22(1). 165–165. 14 indexed citations
3.
Torrejon, Davis Y., Gabriel Abril-Rodríguez, Katie M. Campbell, et al.. (2023). Antitumor Immune Responses in B2M -Deficient Cancers. Cancer Immunology Research. 11(12). 1642–1655. 22 indexed citations
4.
Nguyen, Vina P., Katie M. Campbell, Theodore S. Nowicki, et al.. (2023). A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. Cancer Research Communications. 3(8). 1628–1637. 10 indexed citations
5.
Campbell, Katie M., Shannon M. Pfeiffer, Timothy R. Howes, et al.. (2023). Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma. Cancer Cell. 41(4). 791–806.e4. 50 indexed citations
6.
Abril-Rodríguez, Gabriel, Davis Y. Torrejon, Daniel Karin, et al.. (2022). Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade. Cancer Research Communications. 2(10). 1214–1228. 8 indexed citations
7.
Campbell, Katie M., Egmidio Medina, Anusha Kalbasi, et al.. (2022). Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy. Journal for ImmunoTherapy of Cancer. 10(3). e004190–e004190. 5 indexed citations
8.
Lacouture, Mario E., Zev A. Wainberg, Anisha B. Patel, et al.. (2021). Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy. Cancer Discovery. 11(9). 2158–2167. 16 indexed citations
9.
Kim, Yeon Joo, Katherine M. Sheu, Jennifer Tsoi, et al.. (2021). Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy. Journal of Clinical Investigation. 131(12). 40 indexed citations
10.
Grasso, Catherine S., Jennifer Tsoi, Mykola Onyshchenko, et al.. (2020). Abstract 3166: The degree of conserved interferon gamma signaling guides response to immune checkpoint blockade therapy. Cancer Research. 80(16_Supplement). 3166–3166. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026